|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED-B
Nominal 
33.300 +2.300 (+7.419%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (769,190) | (1,155,761) | (729,936) | (471,899) |
| Net Cash from / (used in) Investing Activities | -- | 752,497 | (1,028,025) | (975,816) | (519,930) |
| Net Cash from / (used in) Financing Activities | -- | 10,103 | (25,311) | (76,508) | 5,637,884 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (6,590) | (2,209,097) | (1,782,260) | 4,646,055 |
| Cash & Cash Equivalents at beginning of period | -- | 490,788 | 2,640,053 | 4,481,122 | 106,061 |
| Effect of Foreign Exchange Rate Changes | -- | 38,865 | 59,832 | (58,809) | (270,994) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 523,063 | 490,788 | 2,640,053 | 4,481,122 |
| Remarks: | Real time quote last updated: 04/11/2024 14:55 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -632,413,000 |
| %Change | 49.291% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 13.567 |